Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

Los Angeles California 90027

A clinical trial to evaluate treatments using MOD-5014 for patients with Hemophilia A or Hemophilia B

Florida

University of South Florida- Morsani Center for Advanced Healthcare
Tampa Florida 33612

Study of Prophylaxis, ACtivity and Effectiveness (SPACE) in Hemophilia Patients Currently Treated With ADVATE or RIXUBIS

Indiana

Indianapolis Indiana 46260

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Maryland

St. Louis Maryland 63104

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Michigan

East Lansing Michigan 48823

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Minnesota

Minneapolis Minnesota 55404

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Ohio

Columbus Ohio 43205

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Turkey

UPDATED

Many Locations

A clinical study for patients with Hemophilia

Canada

Toronto Ontario M5G 1X8

A clinical trial seeking patients for a research study for the treatment of Hemophilia or Hemophilic Arthropathy

Ireland

Dublin

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Italy

Bologna Emilia Romagna 40138

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Cosenza Calabria 87100

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Florance 50139

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Florence Tuscany 50134

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Genova 16148

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

View More ▼

Milan 20122

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Padova 35128

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Padua Veneto 35128

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Palermo

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Rome 165

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Rome 161

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Rome Lazio 00165

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Turin Piemonte 10126

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Turin Piemonte 10126

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Udine Friuli Venezia Giulia 33100

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

Vicenza Veneto 36100

Patients are needed to participate in a clinical research study evaluating TGA (Thrombin generation Assay) for the treatment of Severe Hemophilia A With Inhibitor

New Zealand

Christchurch

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Spain

Barcelona

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Madrid 28046

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Sweden

Stockholm 171 76

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

United Kingdom

Basingstoke Hampshire RG24 9NA

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Cambridge Cambridgeshire CB2 2QQ

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

Cardiff CF14 4XW

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

London WC1N3JH

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A

London SE1 1YR

A clinical trial to evaluate treatments using ALN-AT3SC for patients with Moderate or Severe Hemophilia A or Hemophilia B

View More ▼

Whitechapel London E1 188

A clinical research study of BIIB031 (rFVIIIFc) for the treatment of Hemophilia A, Severe Hemophilia A